2024 Financial Year |
30 Apr 2024 |
Bubs Q3 FY24 Quarterly Activity and Cashflow Statement
|
View PDF
|
27 Mar 2024 |
ASX Conference – Investor Presentation
|
View PDF
|
25 Mar 2024 |
BUBs Investor Update – Pathway to Profitability
|
View PDF
|
18 Mar 2024 |
Bubs US Growth Continues at Pace
|
View PDF
|
14 Mar 2024 |
Investor Webinar Presentation
|
View PDF
|
26 Feb 2024 |
Bubs Australia – Half Year Report and Appendix 4D
|
View PDF
|
26 Feb 2024 |
Bubs Australia – Half Year Results Commentary
|
View PDF
|
26 Feb 2024 |
Bubs Australia – Half Year Results Presentation
|
View PDF
|
23 Feb 2024 |
H1 FY24 Results Presentation – Details of Briefing
|
View PDF
|
31 Jan 2024 |
Bubs Q2 FY24 Quarterly Activity and Cashflow Statement
|
View PDF
|
21 Dec 2023 |
Bubs Results of Share Purchase Plan
|
View PDF
|
1 Dec 2023 |
Bubs Share Purchase Plan Offer Opens and SPP Booklet
|
View PDF
|
30 Nov 2023 |
Cleansing Notice
|
View PDF
|
24 Nov 2023 |
Proposed issue of securities – BUB
|
View PDF
|
24 Nov 2023 |
Capital Raising Investor Presentation
|
View PDF
|
24 Nov 2023 |
Completion of $14M Placement and Launches SPP
|
View PDF
|
22 Nov 2023 |
Trading Halt
|
View PDF
|
14 Nov 2023 |
2023 Annual General Meeting – CEO Address
|
View PDF
|
14 Nov 2023 |
Results of 2023 Annual General Meeting
|
View PDF
|
14 Nov 2023 |
2023 Annual General Meeting – CEO Presentation
|
View PDF
|
14 Nov 2023 |
2023 Annual General Meeting – Chair Address
|
View PDF
|
7 Nov 2023 |
Bubs Governance Changes
|
View PDF
|
24 Oct 2023 |
Q1 FY24 Quarterly Activities Report & Appendix 4C Cashflow Statement
|
View PDF
|
18 Oct 2023 |
Application for quotation of securities – BUB
|
View PDF
|
18 Oct 2023 |
Notice of Annual General Meeting/Proxy Form
|
View PDF
|
18 Oct 2023 |
Bubs Annual General Meeting – Notice of Access
|
View PDF
|
26 Sep 2023 |
Bubs – Date of AGM Notification
|
View PDF
|
12 Sep 2023 |
FY23 Results Presentation Webinar
|
View PDF
|
7 Sep 2023 |
FY23 Results Presentation
|
View PDF
|
7 Sep 2023 |
Appendix 4G.
|
View PDF
|
7 Sep 2023 |
Bubs Corporate Governance Statement
|
View PDF
|
7 Sep 2023 |
FY23 Annual Report to Shareholders
|
View PDF
|
7 Sep 2023 |
US-Based Infant Formula Clinical Trial
|
View PDF
|
31 Aug 2023 |
Bubs 2023 Appendix 4E – Preliminary Final Report
|
View PDF
|
31 Aug 2023 |
Bubs FY23 Results
|
View PDF
|
29 Aug 2023 |
CEO Appointment
|
View PDF
|
31 Jul 2023 |
Q4 FY23 Quarterly Activities Report and Appendix 4C Cashflow Statement
|
View PDF
|
27 Jul 2023 |
Shareholders Vote of Confidence for Board – Board retained as all resolutions voted down
|
View PDF
|
27 Jul 2023 |
Results of Extraordinary General Meeting
|
View PDF
|
27 Jul 2023 |
Bubs Extraordinary General Meeting
|
View PDF
|
12 Jul 2023 |
Alpha Group Legal Dispute Update
|
View PDF
|
6 Jul 2023 |
Strategic Review Update Presentation
|
View PDF
|
6 Jul 2023 |
Strategic Review Update Presentation (Mandarin)
|
View PDF
|
6 Jul 2023 |
Strategic Review Outcome
|
View PDF
|
4 Jul 2023 |
Strategic Review Details of Webcast
|
View PDF
|
3 Jul 2023 |
Alpha Group Legal Dispute
|
View PDF
|
2023 Financial Year |
30 Jun 2023 |
Bubs China Update
|
View PDF
|
22 Jun 2023 |
Notice of Meeting (Mandarin)
|
View PDF
|
22 Jun 2023 |
Proxy Form
|
View PDF
|
22 Jun 2023 |
Notice of Meeting
|
View PDF
|
22 Jun 2023 |
Letter from Chair
|
View PDF
|
21 Jun 2023 |
USA Update
|
View PDF
|
9 Jun 2023 |
Important Information TAKE NO ACTION (Mandarin)
|
View PDF
|
9 Jun 2023 |
Important Information TAKE NO ACTION
|
View PDF
|
2 Jun 2023 |
Notice Proposing Removal of Directors
|
View PDF
|
2 Jun 2023 |
Trading Update
|
View PDF
|
10 May 2023 |
Bubs Australia Limited – CEO Termination
|
View PDF
|
28 Apr 2023 |
Q3 FY23 Quarterly Activities Report and Appendix 4C Cashflow Statement
|
View PDF
|
28 Feb 2023 |
Bubs 1H FY23 Results Commentary
|
View PDF
|
28 Feb 2023 |
Bubs 1H FY23 Results Presentation
|
View PDF
|
25 Feb 2023 |
Board Charter
|
View PDF
|
25 Feb 2023 |
Nomination Committee Charter
|
View PDF
|
30 Sep 2022 |
Bubs Lodges Letter of Intent with FDA for Permanent Market Access in USA to October 2025 and Beyond
|
View PDF
|
28 Sep 2022 |
SAMR Registration Pathway for Bubs China Label Infant Formula
|
View PDF
|
30 Aug 2022 |
Bubs FY22 Annual Results Presentation
|
View PDF
|
30 Aug 2022 |
Bubs FY22 Annual Results Commentary
|
View PDF
|
30 Aug 2022 |
Bubs FY22 Annual Report
|
View PDF
|
30 Aug 2022 |
Appendix 4G
|
View PDF
|
30 Aug 2022 |
Corporate Governance Statement
|
View PDF
|
20 Jul 2022 |
Q4 FY22 Quarterly Activities Report and Appendix 4C Cashflow Statement
|
View PDF
|